Literature DB >> 2921319

Peroxisomal bifunctional enzyme deficiency.

P A Watkins1, W W Chen, C J Harris, G Hoefler, S Hoefler, D C Blake, A Balfe, R I Kelley, A B Moser, M E Beard.   

Abstract

Peroxisomal function was evaluated in a male infant with clinical features of neonatal adrenoleukodystrophy. Very long chain fatty acid levels were elevated in both plasma and fibroblasts, and beta-oxidation of very long chain fatty acids in cultured fibroblasts was significantly impaired. Although the level of the bile acid intermediate trihydroxycoprostanoic acid was slightly elevated in plasma, phytanic acid and L-pipecolic acid levels were normal, as was plasmalogen synthesis in cultured fibroblasts. The latter three parameters distinguish this case from classical neonatal adrenoleukodystrophy. In addition, electron microscopy and catalase subcellular distribution studies revealed that, in contrast to neonatal adrenoleukodystrophy, peroxisomes were present in the patient's tissues. Immunoblot studies of peroxisomal beta-oxidation enzymes revealed that the bifunctional enzyme (enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase) was deficient in postmortem liver samples, whereas acyl-CoA oxidase and the mature form of beta-ketothiolase were present. Density gradient centrifugation of fibroblast homogenates confirmed that intact peroxisomes were present. Immunoblots of fibroblasts peroxisomal fractions showed that they contained acyl-CoA oxidase and beta-ketothiolase, but bifunctional enzyme was not detected. Northern analysis, however, revealed that mRNA coding for the bifunctional enzyme was present in the patient's fibroblasts. These results indicate that the primary biochemical defect in this patient is a deficiency of peroxisomal bifunctional enzyme. It is of interest that the phenotype of this patient resembled neonatal adrenoleukodystrophy and would not have been distinguished from this disorder by clinical study alone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921319      PMCID: PMC303746          DOI: 10.1172/JCI113956

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism.

Authors:  D M Danks; P Tippett; C Adams; P Campbell
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.

Authors:  B T Poll-The; J M Saudubray; H Ogier; R B Schutgens; R J Wanders; G Schrakamp; H van den Bosch; J M Trijbels; A Poulos; H W Moser
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Individual peroxisomal beta-oxidation enzymes.

Authors:  T Hashimoto
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Determination of pipecolic acid in urine and plasma by isotope dilution mass fragmentography.

Authors:  G A van den Berg; H Breukelman; H Elzinga; J M Trijbels; L A Monnens; F A Muskiet
Journal:  Clin Chim Acta       Date:  1986-09-30       Impact factor: 3.786

5.  Neonatal adrenoleukodystrophy: clinical, pathologic, and biochemical delineation of a syndrome affecting both males and females.

Authors:  R Jaffe; P Crumrine; Y Hashida; H W Moser
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

6.  Association of the liver peroxisomal fatty acyl-CoA beta-oxidation system with the synthesis of bile acids.

Authors:  H Hayashi; K Fukui; F Yamasaki
Journal:  J Biochem       Date:  1984-12       Impact factor: 3.387

7.  Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

Authors:  I Singh; A E Moser; S Goldfischer; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.

Authors:  W W Chen; P A Watkins; T Osumi; T Hashimoto; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.

Authors:  S Goldfischer; J Collins; I Rapin; B Coltoff-Schiller; C H Chang; M Nigro; V H Black; N B Javitt; H W Moser; P B Lazarow
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

10.  Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy: a possible new peroxisomal disease entity.

Authors:  S Naidu; G Hoefler; P A Watkins; W W Chen; A B Moser; S Hoefler; N E Rance; J M Powers; M Beard; W R Green
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

View more
  47 in total

Review 1.  Peroxisomal beta-oxidation enzymes.

Authors:  T Hashimoto
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.

Authors:  H Mandel; M Berant; A Aizin; R Gershony; S Hemmli; R B Schutgens; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  A bifunctional protein with deficient enzymic activity: identification of a new peroxisomal disorder using novel methods to measure the peroxisomal beta-oxidation enzyme activities.

Authors:  R J Wanders; C W van Roermund; A Schelen; R B Schutgens; J M Tager; J B Stephenson; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Di- and trihydroxycholestanoic acidaemia with hepatic failure.

Authors:  H Przyrembel; R J Wanders; C W van Roermund; R B Schutgens; G P Mannaerts; M Casteels
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Study of peroxisomal proteins in patients with Zellweger syndrome.

Authors:  J Gärtner; A Balfe; W W Chen; H W Moser
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 7.  Zellweger syndrome and associated phenotypes.

Authors:  D R FitzPatrick
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

8.  D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder.

Authors:  Y Suzuki; L L Jiang; M Souri; S Miyazawa; S Fukuda; Z Zhang; M Une; N Shimozawa; N Kondo; T Orii; T Hashimoto
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 9.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.

Authors:  R Santer; A Claviez; H D Oldigs; J Schaub; R B Schutgens; R J Wanders
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.